0
After therapy with parenteral amiodarone (2300 mg in 3 days) and other measures, signs of congestive heart failure disappeared; subsequently the patient developed jaundice, marked increase in serum transaminase levels and fall in prothrombin time, and histologic changes of severe centrilobular necrosis were observed in hepatic biopsy.
 jaundice, marked increase in serum transaminase levels and fall in prothrombin time, and histologic changes of severe centrilobular necrosis were observed in hepatic biopsy: Effect; parenteral amiodarone (2300 mg in 3 days) and other measures: Treatment; amiodarone: Treatment.Drug; parenteral: Treatment.Route; 2300 mg in 3 days: Treatment.Dosage; congestive heart failure: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 jaundice, marked increase in serum transaminase levels and fall in prothrombin time, and histologic changes of severe centrilobular necrosis were observed in hepatic biopsy: Effect; parenteral amiodarone (2300 mg in 3 days) and other measures: Treatment; amiodarone: Treatment.Drug; parenteral: Treatment.Route; 2300 mg in 3 days: Treatment.Dosage; congestive heart failure: Treatment.Disorder